-
Product Insights
New![]()
Harding Biomass Power Plant
Harding Biomass Power Plant is a biopower project located in KwaZulu-Natal, South Africa. The project is owned and being developed by eThala Management Services. The project is at the permitting stage. Empower your strategies with our Harding Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Washpool Hard Coking Coal Project
The Washpool Hard Coking Coal Project is a coal project in Australia. It is currently at the feasibility stage. Empower your strategies with our Washpool Hard Coking Coal Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
New![]()
Harding Street Gas Power Plant
Harding Street Gas Power Plant is a thermal project located in Indiana, United States. The project is owned by Caisse de depot et placement du Quebec; The AES Corp. The project came online in 2015. Empower your strategies with our Harding Street Gas Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
New![]()
Harding Street Gas Turbine Power Plant
Harding Street Gas Turbine Power Plant is a thermal project located in Indiana, United States. The project is owned by Caisse de depot et placement du Quebec; The AES Corp. The project came online in 1994. Empower your strategies with our Harding Street Gas Turbine Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
![]()
Harding Field, United Kingdom
Harding upstream field is located in North Sea, United Kingdom. The upstream field is owned by TAQA Bratani Ltd (70%); TotalEnergies E&P North Sea UK Ltd (30%). It is operated by TAQA Bratani Ltd. The project started its operations in 1996. Harding Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end years, reserves...
-
![]()
Hard Rock Hotel – Hard Rock Hotel and Casino Ottawa – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hard Rock Hotel – Hard Rock Hotel and Casino Ottawa – Ontario report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Fedratinib in Myelodysplastic Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Fedratinib in Myelodysplastic Syndrome Drug Details:Fedratinib (Inrebic, Fedratinib dihydrochloride) is an antineoplastic agent. It is formulated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Fedratinib in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Fedratinib in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)Drug Details:Fedratinib (Inrebic, Fedratinib dihydrochloride) is an antineoplastic agent. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GB-1211 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GB-1211 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: GB-1211 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GB-1211 in Decompensated Cirrhosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GB-1211 in Decompensated Cirrhosis Drug Details: GB-1211 is under development for the treatment of liver cirrhosis,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ACT-10041239 in Demyelinating Diseases
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ACT-10041239 in Demyelinating Diseases Drug Details: ACT-10041239 is under development for the treatment of unspecified...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Neflamapimod in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Neflamapimod in Alzheimer's Disease Drug Details: Neflamapimod (VX-745) is under development for the treatment of Alzheimer’s...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ACT-10041239 in Multiple Sclerosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ACT-10041239 in Multiple Sclerosis Drug Details: ACT-10041239 is under development for the treatment of unspecified...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NVDX-3 in Bone Fracture
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NVDX-3 in Bone Fracture Drug Details: NVD-X3 is under development for hard tissue reconstruction in...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TTI-101 in Head And Neck Squamous Cell Carcinoma (HNSC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TTI-101 in Head And Neck Squamous Cell Carcinoma (HNSC) Drug Details: TTI-101 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ritlecitinib in Vitiligo
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ritlecitinib in Vitiligo Drug Details: Ritlecitinib (Litfulo) acts as an anti inflammatory agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ritlecitinib in Mycosis Fungoides
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ritlecitinib in Mycosis Fungoides Drug Details: Ritlecitinib (Litfulo) acts as an anti inflammatory agent. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TTI-101 in Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TTI-101 in Breast Cancer Drug Details: TTI-101 is under development for the treatment of unspecified...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TTI-101 in Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TTI-101 in Melanoma Drug Details: TTI-101 is under development for the treatment of unspecified cancers,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TTI-101 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TTI-101 in Gastric Cancer Drug Details: TTI-101 is under development for the treatment of unspecified...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.